Verteporfin Suppresses YAP-Induced Glycolysis in Breast Cancer Cells

Hippo signaling pathway: A comprehensive gene expression profile analysis in breast cancer

(2022) Hassan Yousefi et al.   BIOMEDICINE & PHARMACOTHERAPY

Small-Molecule Cyanamide Pan-TEAD·YAP1 Covalent Antagonists

(2022) Khuchtumur Bum-Erdene et al.   Journal of Medicinal Chemistry

In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy

(2021) Meiou Dai et al.   Nature Communications

Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor Verteporfin in preclinical glioblastoma models

(2021) Anne Marie Barrette et al.   NEURO-ONCOLOGY

Integration of Hippo-YAP Signaling with Metabolism

(2020) Consuelo Ibar et al.   DEVELOPMENTAL CELL

HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis

(2020) Marta Palomo-Irigoyen et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

(2020) Anwesha Dey et al.   NATURE REVIEWS DRUG DISCOVERY

Breast Cancer Treatment

(2019) Adrienne G. Waks et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?

(2019) Gary A. Ulaner   AMERICAN JOURNAL OF ROENTGENOLOGY

Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update

(2019) Joseph A. Clara et al.   Nature Reviews Clinical Oncology

The Hippo Signaling Network and its Biological Functions

(2018) Jyoti R. Misra et al.   Annual Review of Genetics

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Interplay between YAP/TAZ and Metabolism

(2018) Ja Hyun Koo et al.   Cell Metabolism

Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1

(2017) Kotb Abdelmohsen et al.   RNA Biology

Non-Photoinduced Biological Properties of Verteporfin

(2016) Floriane Gibault et al.   CURRENT MEDICINAL CHEMISTRY

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

(2015) Fa-Xing Yu et al.   CELL

Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma

(2015) L.-F. Zhang et al.   EMBO JOURNAL

Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction

(2014) Zhisen Zhang et al.   ACS Medicinal Chemistry Letters

A novel miR-155/miR-143 cascade controls glycolysis by regulatinghexokinase 2in breast cancer cells

(2012) Shuai Jiang et al.   EMBO JOURNAL

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

(2012) Y. Liu-Chittenden et al.   GENES & DEVELOPMENT

Targeting cancer metabolism: a therapeutic window opens

(2011) Matthew G. Vander Heiden   NATURE REVIEWS DRUG DISCOVERY

TEAD mediates YAP-dependent gene induction and growth control

(2008) B. Zhao et al.   GENES & DEVELOPMENT